What is Janus Development Group?
Janus Development Group operates at the intersection of medical technology and speech pathology, providing innovative hardware and software solutions designed to enhance communication for individuals with speech fluency disorders. The company's flagship product, SpeechEasy, is a discreet, custom-fit device engineered to assist those who stutter, as well as patients managing speech challenges associated with Parkinson's disease. Complementing this hardware, the firm offers FluencyCoach, a proprietary software platform that serves as a digital gateway to their technology. By focusing on both physical devices and accessible software, Janus Development Group addresses a critical need for improved speech intelligibility and user confidence, establishing itself as a key player in the assistive technology landscape.
How much funding has Janus Development Group raised?
Janus Development Group has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
Key Investors in Janus Development Group
PPP
Public-Private Partnership
What's next for Janus Development Group?
With the recent injection of capital, Janus Development Group is expected to prioritize the scaling of its manufacturing capabilities and the expansion of its clinical outreach programs. The current Series B/C stage indicates a transition from initial product validation to broader commercialization. Strategic initiatives will likely include the refinement of their custom-fit models and the potential integration of advanced diagnostic features into the FluencyCoach ecosystem. As the company matures, the focus will shift toward securing wider insurance coverage and establishing deeper partnerships with speech-language pathology clinics, ensuring that their assistive technology remains at the forefront of the industry while driving sustainable long-term growth.
See full Janus Development Group company page
